home / stock / crmd / crmd news


CRMD News and Press, CorMedix Inc. From 03/15/21

Stock Information

Company Name: CorMedix Inc.
Stock Symbol: CRMD
Market: NYSE
Website: cormedix.com

Menu

CRMD CRMD Quote CRMD Short CRMD News CRMD Articles CRMD Message Board
Get CRMD Alerts

News, Short Squeeze, Breakout and More Instantly...

CRMD - CorMedix Approved to Sell $1.3 Million of NOL Tax Benefits Through The New Jersey Economic Development Authority Program

BERKELEY HEIGHTS, N.J., March 15, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it has been appro...

CRMD - CorMedix: Resolvable CRL And Low Price Make It Attractive

CRMD received a CRL that looks resolvable. The Defencath system has seen solid data. There are some negatives; however, the pros outweigh the risk. For further details see: CorMedix: Resolvable CRL And Low Price Make It Attractive

CRMD - CorMedix Inc. Announces Contract Extension of Liz Masson-Hurlburt as Executive Vice President and Head of Clinical Operations

BERKELEY HEIGHTS, N.J., March 11, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it has entered in...

CRMD - CorMedix Inc. to Host Regulatory Update Conference Call

BERKELEY HEIGHTS, N.J., March 08, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will host a co...

CRMD - Wall Street Breakfast: What Moved Markets

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks powered higher after a slow start Friday as U.S. Treasury yields fell back from early highs. All major groups in the S&P 500 finis...

CRMD - Why CorMedix Stock Is Crashing Today

Shares of CorMedix (NASDAQ: CRMD) were crashing 40.4% as of 12:23 p.m. EST on Monday. The steep decline came after the company announced that the Food and Drug Administration isn't approving CorMedix's Defencath, an antibacterial/antifungal catheter lock, for preventing blood infect...

CRMD - SOS, MNKD, CAN and OTRK among midday movers

Gainers: Morphic (MORF) +106%.Aemetis (AMTX) +58%.SOS (SOS) +43%.Canaan (CAN) +41%.electroCore (ECOR) +37%.Vector Acquisition (VACQU) +37%.The9 (NCTY) +36%.One Stop Systems (OSS) +30%.HCI Group (HCI) +29%.ZK International (ZKIN) +27%.Losers: Athenex (ATNX) -52%.O...

CRMD - Morphic, electroCore leads healthcare gainers; Athenex, Ontrak among major losers

Gainers: Morphic (MORF) +104%, electroCore (ECOR) +51%, Apollo Endosurgery (APEN) +24%, ASLAN Pharmaceuticals (ASLN) +23%, Satsuma Pharmaceuticals (STSA) +19%.Losers: Athenex (ATNX) -51%, Ontrak (OTRK) -48%, CorMedix (...

CRMD - CorMedix shares crash on FDA's DefenCath complete response letter

CorMedix (CRMD) shares plummet 50% premarket after announcing that the U.S. FDA has declined to approve its DefenCath catheter lock solution, citing concerns at its third-party manufacturing facility.FDA, in its complete response letter, did not specify the issues and CorMedix ...

CRMD - CorMedix Receives Complete Response Letter From FDA for DefenCath(TM) Catheter Lock Solution

BERKELEY HEIGHTS, N.J., March 01, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, announced today that the US Food and D...

Previous 10 Next 10